Unknown

Dataset Information

0

Investigating Real-World Clopidogrel Pharmacogenetics in Stroke Using a Bioresource Linked to Electronic Medical Records.


ABSTRACT: Clopidogrel efficacy is influenced by genetic variation of cytochrome P450 (CYP)2C19, however, few studies have considered patients who have a stroke. We used electronic medical records (EMRs) linked to a bioresource to examine real-world implications of clopidogrel pharmacogenetics in stroke. Patients hospitalized for any arterial thrombo-occlusive (ATO) event who subsequently redeemed clopidogrel prescriptions in the community were entered into the study (n = 651). During 24-month follow-up, the primary endpoint of recurrent ATO or death occurred in 299 patients (46%). CYP2C19*2 loss-of-function allele carriers had an increased risk (hazard ratio (HR) = 1.29; 95% confidence interval (CI) = 1.04-1.59; P = 0.019). In the ischemic stroke subgroup (n = 94), the estimate of risk was greater (HR = 2.23; 95% CI = 1.17-4.24; P = 0.015), which was further supported by a meta-analysis of available studies. In conclusion, we have demonstrated the clinical impact of CYP2C19*2 on clopidogrel efficacy using a purely EMR approach. This suggests that the risk in the ischemic stroke population may be particularly high.

SUBMITTER: Tornio A 

PROVIDER: S-EPMC5813097 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Investigating Real-World Clopidogrel Pharmacogenetics in Stroke Using a Bioresource Linked to Electronic Medical Records.

Tornio Aleksi A   Flynn Rob R   Morant Steve S   Velten Elena E   Palmer Colin N A CNA   MacDonald Thomas M TM   Doney Alex S F ASF  

Clinical pharmacology and therapeutics 20170919 2


Clopidogrel efficacy is influenced by genetic variation of cytochrome P450 (CYP)2C19, however, few studies have considered patients who have a stroke. We used electronic medical records (EMRs) linked to a bioresource to examine real-world implications of clopidogrel pharmacogenetics in stroke. Patients hospitalized for any arterial thrombo-occlusive (ATO) event who subsequently redeemed clopidogrel prescriptions in the community were entered into the study (n = 651). During 24-month follow-up, t  ...[more]

Similar Datasets

| PRJNA158491 | ENA
| S-EPMC3690348 | biostudies-other
| S-EPMC4916370 | biostudies-literature
| S-EPMC6581205 | biostudies-literature
| S-EPMC11011132 | biostudies-literature
| S-EPMC8126538 | biostudies-literature
| S-EPMC7781803 | biostudies-literature
| S-EPMC9633387 | biostudies-literature
| S-EPMC7772071 | biostudies-literature